Group items tagged

Reports and Insights freshly added a report titled "Chronic Ocular Graft-Versus-Host Disease Market: Opportunity Analysis and Future Assessment 2023-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the Chronic Ocular Graft-Versus-Host Disease Market along with the compound growth rate (CAGR) of the market for a forecasted period between 2023 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  The global chronic ocular graft-versus-host disease market in 2020 is accounted for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of 4.2%. Chronic Ocular Graft-Versus-Host Disease Market: https://reportsandinsights.com/sample-request/1225 Chronic Ocular Graft-Versus-Host Disease Market Dynamics The rising prevalence of bone marrow cancers and the increasing number of road accidents among individuals across the globe are the major factors driving the growth of the global chronic ocular graft-versus-host disease market. For instance, according to data published by World Health Organization (WHO), in September 2018, Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 Mn deaths in 2018. Moreover, growing research and development activities on diagnosis management, coupled with a huge new pipeline of drugs are further propelling the growth of the global chronic ocular graft-versus-host disease market. However, factors such as low societal awareness, delayed diagnosis, and low go

The report is titled as 'Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Chronic Obstructive Pulmonary Disease (COPD) Treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

Global Chronic Obstructive Pulmonary Disease Market Size Report 2025

Chronic Obstructive Pulmonary Disease Market

Recently, a latest report emphasizing on the evolution and progress of the global Clinical Nutrition Market has been posted to the huge database of Reports and Insights, entitled "Global Clinical Nutrition Market 2022 Report". The report renders qualitative and quantitative synopsis of the conceptual framework and rational approach of the market together with the data related to market size, segmentation, textual & graphical assessment of the global market growth trends over the forecast period of 2022 to 2030. The clinical nutrition market is estimated to reach at a value of US$ 30.1 Bn by the end of 2022 and expected to reach at a value of US$ 47.8 Bn by 2030 with a significant CAGR of 6.0%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1968 Clinical Nutrition Introduction Good food and nutrition have always had a huge significance for the personal health and well-being of any individual. In a similar manner, healthy food and good nutrition can play a great role in speedy recovery of patients suffering from various medical conditions. The term 'clinical nutrition' can be perceived as a discipline which acts towards the prevention, diagnosis and management of nutritional and metabolic changes associated with chronic and acute diseases and medical conditions caused by excess or short of nutrients and energy. Clinical nutrition consists of the nutritional care of patients suffering with obesity, cardiovascular disease, dyslipidaemias, diabetes, food allergies and intolerances, innate fallacies of metabolism as well as any illness where nutrition holds a crucial role such as stroke, cancer, cystic fibrosis and many others. Clinical Nutrition Market Dynamics The surging prevalence of chronic medical conditions among the population, worldwide, such as cardiovascular diseases, diabetes and cancer together with a rising geriatric population base is majorly boosting the demand of clinical nutrition as patients su

Researchers from the Stanford University School of Medicine have devised a new blood test for the identification of chronic fatigue syndrome (CFS), a debilitating condition that lacks a standard diagnostic test.

"The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth. Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation."

Chronic pain, which includes illnesses like low back pain and osteoarthritis, was recently highlighted as one of the most common causes of disability worldwide by the Global Burden of disease studies in a meta-analysis study. Reference : https://bit.ly/3Ki4o96 Our services : https://pubrica.com/services/research-services/meta-analysis/ Why Pubrica: When you order our services, We promise you the following - Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.   Contact us:      Web: https://pubrica.com/  Blog: https://pubrica.com/academy/  Email: sales@pubrica.com  WhatsApp : +91 9884350006  United Kingdom: +44-1618186353

The latest report published by Reports & Insights highlighted the development and the growth of the global Biologics Market, which further includes the detailed information about the market potential and profound knowledge of the trends prevailing in the market. The global Biologics Market is projected to rise steadily over the anticipated future as per the report estimates. The research study named "Biologics Market: Opportunity Analysis and Future Assessment 2020-2028", is aimed to provide a quantitative and qualitative outline of the conceptual structure and analytical approach of the market elaborated using attested research methodologies and proficient expertise. The biologics market is estimated to reach at a value of US 339.3 Bn by the end of 2022 and expected to reach at a value of US$ 610.2 Bn by 2030 with a significant CAGR of 7.6%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/2349 Biologics Introduction Biologics, or a biologic drug, is a substance that is made from living creatures or comprise elements of living creatures. Biologic drugs consist of an extensive range of by-products obtained from microorganisms, animals, and humans by the usage of biotechnology. The various kinds of biologic drugs or biologics comprises blood and its components, cells, vaccines, genes, allergens, tissues, and recombinant proteins. Biologics Market Dynamics A biologic is created in a life system including animal or plant cells, or microorganisms that are majorly used to impede, diagnose, and to treat, or cure a wide range of illnesses such as chronic kidney disease, cancer, infectious diseases, and autoimmune disorders. In the present times, the rising incidence of chronic diseases such as autoimmune diseases, diabetes, and cancer among the population owing to the lethargic lifestyle, poor diet, and desk-bound jobs is mainly encouraging the demand of biologics in the global market, thus propelling the growth of the

Reports and Insights freshly added a report titled "Pharma Drug Delivery Market: Opportunity Analysis and Future Assessment 2022-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the Pharma Drug Delivery Market along with the compound growth rate (CAGR) of the market for a forecasted period between 2022 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  The global pharma drug delivery market is estimated to reach at a value of US$ 1,422.8 Bn by the end of 2020 and expected to reach at a value of US$ 2,418.4 Bn by 2028 with a significant CAGR of 6.9% Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1393 Pharma Drug Delivery Introduction A pharmaceutical drug delivery (DDS) is a fabrication or an equipment, which is used for the infusion of a therapeutic matter into the human body. This system operates by administering medications to precisely targeted parts of the body by the help of a means, which can regulate the administration of the therapy by the medium of each of two chemical or physiological prompts. The drug delivery system is mainly employed to enhance the efficiency and safety of an infused drug by regulating the time, degree, and part of dispensation of drug in the body. Moreover, drug delivery systems are also bifurcated into further two types including conventional drug delivery system and novel drug delivery system. Conventional drug delivery system involves the most general techniques of drug deliver

Reports & Insights freshly released a new report entitled as "Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2022-2030", in which the base year is considered for the study is 2021, estimated year is 2022, and the forecasted year is considered 2023-2030. The global Digital Therapeutics Market in 2022 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ $ 22.9 Bn by 2030 with a significant CAGR of 25.8%. The report promises to offer its clients with an absolute across-the-board, premium quality primary data about the market prospects and in-depth knowledge of the trends prevailing in the market. The report further aims to provide a quantitative and qualitative synopsis of the theoretical framework and rational approach of the market expatiate using certified research methodologies and proficient expertise. The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1123 Digital Therapeutics Introduction The digital Therapeutics market includes a couple of segments such as application and end-use. The application segment further divided into six other categories such as diabetes, obesity, CVD, CNS, respiratory, and others. The end-user segment is further divided into patients, caregivers, employers, payers, and pharmaceutical companies. Furthermore, the study includes market estimation, market forecast, and market information for six geographical regions around the globe. In 2016, in the U.S. diabetes is the seventh major cause of death, which affects around 10% of the U.S. population that is around 30.0 million and around  95% of diabetic patients have type 2 diabetes that is significantly associated with behavioral factors such as heavy calorie intake and less physical activity. Digital Therapeutics Market Dynamics

The "Asthma Drugs Market: Opportunity Analysis and Future Assessment 2022-2030" research report offers a comprehensive and an in-depth evaluation of the progressive market trends, growth areas, opportunities, drivers, and restraints, which would allow clients and stakeholders to line up their market strategies as stated in present & future market dynamics. The Asthma Drugs Market is estimated to escalate at around 5.3% CAGR during 2022-30. A strategic assessment of the market growth trajectory in the forecast period, whilst taking into account the Covid-19 impact on the industry, is also included in the research study, with certain information established by research experts.  The global asthma drugs market is estimated to reach at a value of US$ 24.0 Bn by the end of 2022 and expected to reach at a value of US$ 36.3 Bn by 2030 with a significant CAGR of 5.3% Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/4683 Asthma Drugs Introduction Asthma is basically an inveterate respiratory ailment obstructing the respiratory tracts of the lungs owing to the mucus production, inflammation, and contraction of muscles. Also, Chronic Obstructive Pulmonary Disease (COPD) is further a chronic ailment induced by blockage in the respiratory tracts leading to trouble in breathing, with the main reason being smoking tobacco. Asthma Drugs Market Dynamics One of the major factors that is accelerating the demand of asthma drugs across the global markets is the rapidly growing prevalence of asthma and COPD patients across the world. In addition to that, the rapid growth in the geriatric population across the globe along with numerous technological advancements in the healthcare sector is also playing a positive role in boosting the demand of asthma drugs across the market. Moreover, growth in pipeline products as well as rise in numerous initiatives commenced by the regulatory bodies and non-government associations in order to sp

Have you (or someone you know) struggled with fatigue, headaches, joint or muscle pain, eye issues, skin problems, disrupted sleep, anxiety/depression or other complaints where your doctor told you that there is nothing wrong? All the labs came back "normal." They perhaps offered you an antidepressant, or referred you along to yet another specialist? Many times, symptoms such as these will end up being related to chronic infections, especially tick borne infections. The term Lyme Disease refers to illness from a corkscrew shaped bacteria called Borrelia Burgdorferi. But it is almost never the only infection at play when you have these symptoms. There are a collection of bacteria, viruses and even parasites that seem to run together to result in this chronic illness often referred to as Lyme Disease.

The US Food and Drug Administration (FDA) has now approved the use of Omalizumab, commercially known as Xolair, for the treatment of chronic hives

The Indian pharma and research firm Dr Reddy's Laboratories announced the launch of generic Paricalcitol injection in the US for treatment associated with chronic kidney disease. In a filing with BSE, the company announced the launch of two injections in the 2mcg, 5mcg, and 10mcg range.

Reasons of Austrias lack of capital in the 19th century Chronic lack of capital for Austria during the 19th century. What were the reasons? Why other European nations had not such problems? Following article should bring the reasons of Austrias biggest problem during the 19th century. I hope you enjoy my work. Before 1870 Those two questions are a good reason to make a closer look on the quest to a proper answer. The lack of capital of was huge problem for Austria in times of the industrialization. There was not enough money for important investments, and other countries like France, England, Belgium, Netherlands and also the German nations had an important advantage towards Austria during the Industrial Age. Austrias problem drew itself to the first world war, became worser in the course of the defeat after 4 years of war, and ended in the disaster of the hyperinflation between 1921 and 1923. Only after the second world war Austria was able to join the club of Europes successful industry nations.

PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.

BLD Stim3 series is one of the most popular and successful devices for physical therapy. It provides all therapies in a single hand-held devices for physical therapist and home care professionals. Stim3 is a 2/4 channel IFT TENS EMS RUSSIAN Stimulator. BLD Stim3 Ideal for : Symptomatic relief of chronic and intractable pain. Adjunctive treatment of post-surgical and post-traumatic acute pain conditions. Multiwaveform device to deliver different treatments. Handy portable device. 2 different patients can be treated simultaneously. Facility of locking a particular treatment for patient. Can be operated via battery as well as with adapter. BLD Stim3 Technical Specifications: Main power supply - 230 Vac, 50-60Hz, ±10%- 115 Vac, 50-60 Hz*, ±10% Channels - 4 / 2 Interfential - IF LOW, IF HIGH, IF WIDE & IF FIXED TENS - Conventional, Burst and Modulation Interfential (IFT) Carrier - 5000 Hz. EMS/TENS - 1-150 Hz Pulse Width - 50-250 μS(TENS);200-450 μS (EMS) Ramp Up/Down - 1-10 Sec Contraction / Relaxation Time - 1-30 Sec Output Voltage - 50 V pp Electrical Type - TYPE BF Cooling system - Inbuilt Cooling Fan BLD Stim3 Special Features: Matrix LCD Display. Intensity Controls For Each Channel. Low Battery Indicator. Treatment Lock-Out. Compliance Monitor. BLD Stim3 Price and Item Code: Item Code: WCI-145 MRP: Rs 14000 Our Price: Rs 13000 Net Price: Rs 12740 ( Apply Coupon Code 'MSW2365' Get 2% Discount ) BLD Stim3 Stimulator is a Electric Stim Machine supplier, distributor and dealer of Portable Stim Machine for Physical Therapy in india, Buy Stim Unit, TENS EMS Unit Online Shopping, Tens EMS Machine Price, Physical Therapy Machine For Sale, Tens EMS Stimulator, Russian Stim Unit, Interferential Stim, Stim Machine Physical Therapy.

Weight gain: Mango Juice is highly beneficial in gaining weight because of the presence of adequate amount of protein both in milk and mango. The underweight people can drink mango juice regularly during summer. 150 grams of mango has about 86 calories, and starch easily converts into sugar thereby helps in weight gain. This is the most important health benefits of mango juice. However, obese person should avoid drinking of mango Juice. Good for anemia patient: The mango Juice is the most delicious juice and filled with important nutrients like iron, protein and beta-carotene. It is good for anemia patient and those have protein deficiency. One of the important benefits of mango juice is to increase red blood cells count in the body. Mango juice also has significant amount of iron. Regular drinking of one glass of mango juice is enough to provide necessary amount of iron to the body. Mango juice is also beneficial for pregnant mother as far as iron content is concern. A number of studies have shown that iron content is beneficial in reduction of muscle cramp, anxiety, stress and heart related problems. Good for eyes: Mango contains vitamin A, which is beneficial for eyes and skin. The sufficient amount of vitamin A helps the eyes against dryness, night blindness along with facilitating good eye sight. Strengthen bones: Milk, which is the integral part of mango juice, is having vitamin D and calcium, helps in strengthening of bones. Maintains blood pressure: Mango juice is rich in potassium and magnesium, which helps to keep blood pressure under control. Potassium assists the heart and regulates blood pressure as well as balance fluids in your body. Mango juice also lowers blood pressure due to tinnginya fiber, pectin and vitamin C. Pectin and vitamin C reduces the serum cholesterol levels, especially the low-density lipoprotein For heart health: Mango in Mango Drinks has high amount of pectin, a dietary fiber and helpful in lowering cholesterol

CP Child Wheelchair Cerebral palsy (CP) is a disorder of the brain. Normally, the brain tells the rest of the body exactly what to do and when to do it.CP affects the brain, a person might not be able to walk, talk, eat, or move the way most people do. CP affects a person's muscle tone and ability to coordinate body movements. People with CP have trouble controlling their muscles. CP affects the part of the brain that controls speech, a person with CP might have trouble talking clearly or not be able to speak at all. Because cerebral palsy affects muscle control, some people have learning disabilities or behavior problems - though many people with CP don't have these issues. Other people with CP also have medical problems like seizures or epilepsy, or hearing impairment. CP may work with these experts: a pediatric orthopedist a developmental pediatrician who looks at how the person is growing or developing compared with other teens a pediatric physiatrist (or rehabilitation physician), who helps kids with disabilities of many kinds therapists, like physical therapists to help with movement, occupational therapists to help with skills like handwriting, and speech therapists Features Ultra light weight aluminum alloy frame Epoxy powder coated frame Detachable arm rest provided Height adjustable and detachable head rest Hydraulic reclining high back for a comfortable posture Detachable back and seat pad Extra cushion upholstery provided to under arm, head. Hand brakes provided Safety belt provided Cerebral Palsy Wheelchair Price Cerebral Palsy is a long-term chronic medical condition that requires long-term supportive care services.Cerebral Palsy often have other associative and co-mitigating medical conditions, including cognitive challenges, vision loss, hearing impairment, and seizures. These conditions require diagnosis, treatment and maintenance all at significant cost.The family of an individual with cerebral palsy is like

Chair For Cerebral Palsy Child Cerebral palsy is a condition, not a disease.Child with cerebral palsy has a range of chronic movement and posture disorders as the direct result of brain damage within the areas that control movement.It isn't easy raising and caring for a child with cerebral palsy, but that doesn't mean they are helpless. It can be child's best advocate in the months and years to come, ensuring that it gets the care that's needed. Cerebral means brain-centred while palsy is a lack of muscle control.Cerebral palsy is abbreviated to CP.Cerebral palsy (CP) is a term used to identify a number of neurological impairments typically appearing in infancy or early childhood, according to researchers at the National Institute of Neurological Disorders and Stroke.Child with cerebral palsy have permanent mobility problems caused by brain damage. There is no cure for cerebral palsy, and many children, adolescents and adults can be treated successfully with adaptations, which can improve their capabilities. Characteristics of cerebral palsy in children are: Lack of muscle coordination when performing voluntary movements Stiff muscles and exaggerated reflexes Abnormal walking with one foot or leg dragging Excessive drooling or difficulties swallowing, sucking or speaking Uncontrolled shaking of the body Difficulty with precise motions, such as writing, tying shoe laces or buttoning a shirt Inability to walk and need for a walker or wheelchair Need for extensive, lifelong care Seizures Cerebral palsy has many causes. A brain that has not formed normally. A combination of low blood flow and/or low oxygen to the brain. Bleeding in the brain around the time of birth. Genetic, meaning it is linked to other members of the family. Meningitis, which causes inflammation of the covering of the brain. Brain injury before the age of 2. Premature birth. Chair For CP Child Chair For CP Child can range from very mild where a child learns to w